Executive Summary
On January 7, 2026, 117 US SEC 8-K filings reveal an unprecedented surge in corporate restructuring events, dominated by material definitive agreements (Item 1.01 ~40%), completed acquisitions/dispositions (Item 2.01 ~20%), and officer/director changes (Item 5.02 ~50%), signaling a broad wave of M&A activity, leadership transitions, and financial maneuvers amid opaque disclosures. While neutral sentiment prevails, clusters of delistings, agreement terminations, and equity dilutions introduce systemic distress signals, particularly in biotech and small-cap sectors, potentially amplifying volatility and consolidation trends. Portfolio managers should brace for short-term equity dilution risks and monitor for alpha in post-merger integrations, but exercise caution due to pervasive lack of deal specifics hindering precise valuations.
Tracking the trend? Catch up on the prior Global High-Priority Regulatory Events digest from January 05, 2026.
Investment Signals(5)
- ▲
Completed acquisitions/dispositions across Permian Resources, VisionWave, National Bank Holdings, and others [BULLISH] - Multiples (e.g., Items 1.01+2.01) suggest strategic expansions with potential synergies upon exhibit review
- ▲
Material definitive agreements in Joby Aviation, D-Wave Quantum, Archrock, and SPACs like Texas Ventures [BULLISH] - Signals partnerships/financings in high-growth tech/energy, ripe for momentum plays
- ▲
Delistings/failures to meet standards at Inotiv, Biofrontera, Propanc Biopharma [BEARISH] - Liquidity erosion and distress indicators warrant exits
- ▲
Agreement terminations at Cidara Therapeutics, BiomX, Cartica Acquisition [BEARISH] - Disrupted deals erode confidence and valuation
- ▲
Unregistered equity sales (Item 3.02) in 20+ filings including D-Wave, ASP Isotopes, Interactive Strength [BEARISH] - Widespread dilution risk across small-caps
Risk Flags(4)
- ▼
Cluster of delistings (Inotiv, Biofrontera, Propanc, Permian/Cidara implied) and non-reliance on financials (Unknown #40) signals acute distress in small/mid-caps, risking sector contagion
- ▼
Pervasive opacity in 90%+ of M&A filings (no parties/values disclosed) heightens execution/valuation risks amid high-volume deal rush
- ▼
Financial obligations (Item 2.03 in 15+ filings like FuboTV, Evergy, Ventas) combined with dilutions could strain balance sheets portfolio-wide
- ▼
Extreme officer churn (~50 filings) without reasons raises governance instability red flags across biotech/financials
Opportunities(4)
- ◆
Biotech M&A wave (4D Molecular, SAB Biotherapeutics, Enliven, Jasper, Ventyx) post-deal integrations for alpha via clinical/asset synergies upon financial exhibit diligence
- ◆
Energy sector consolidations (Permian Resources, ASP Isotopes, EON Resources, Black Stone Minerals) as takeover targets amid completed deals
- ◆
SPAC redemptions/terminations (Cartica, T-REX, Columbus) for short opportunities or pivots to new targets
- ◆
Leadership refreshes in larger caps (CF Industries, Aon, CoStar, Warner Bros. Discovery) signaling operational turnarounds
Sector Themes(3)
- ◆
Biotech/pharma dominance in officer changes and M&A (25+ filings: Cidara, Enliven, Centessa, COMPASS, Ventyx), indicating pipeline deals or talent wars amid regulatory pressures
- ◆
Energy/oil & gas M&A surge (Permian, Diversified Energy, EON, Black Stone) with equity issuances, pointing to consolidation amid commodity volatility
- ◆
Broad small-cap/SPAC distress (delistings, terminations, dilutions in Propanc, Inotiv, Cartica), reflecting liquidity crunches and failed business combinations
Watch List(4)
- 👁
Permian Resources/Cidara Therapeutics delisting+M&A cluster - High materiality (9/10,5/10) with control changes; monitor for bankruptcy spillover
- 👁
Biofrontera/Propanc/Inotiv delistings - Critical risk (10/10); track OTC transitions and shareholder actions
- 👁
Joby Aviation/D-Wave Quantum material agreements - Medium-high materiality (8/10,7/10) in eVTOL/quantum tech; watch for partnership reveals
- 👁
Biotech officer churn wave (4D Molecular, SAB, Enliven, Jasper) - Cumulative governance risks; potential for M&A catalysts
Filing Analyses(117)
07-01-2026
Permian Resources Corp filed an 8-K on January 7, 2026 (AccNo: 0001193125-26-006312, Size: 1 MB), announcing entry into a material definitive agreement (Item 1.01), completion of an acquisition or disposition of assets (Item 2.01), notice of delisting or failure to satisfy listing standards (Item 3.01), unregistered sales of equity securities (Item 3.02), material modifications to rights of security holders (Item 3.03), changes in control of registrant (Item 5.01), departures/elections of directors/officers and compensatory arrangements (Item 5.02), amendments to articles of incorporation/bylaws or fiscal year change (Item 5.03), Regulation FD disclosure (Item 7.01), other events (Item 8.01), and financial statements/exhibits (Item 9.01). This indicates a completed merger/acquisition event with significant corporate changes. No specific parties, deal structure, valuation, or financial metrics are disclosed.
07-01-2026
California BanCorp (CA) filed a Form 8-K on January 7, 2026 (AccNo: 0001493152-26-000728, Size: 360 KB), disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), Regulation FD Disclosure under Item 7.01, and Financial Statements and Exhibits under Item 9.01. No specific details on the officer involved, position affected, appointment/resignation status, reasons, or any quantitative data are provided in the filing summary. Sector is not specified.
07-01-2026
4D Molecular Therapeutics, Inc. disclosed an Officer Change event via Form 8-K filed on 2026-01-07 (AccNo: 0001193125-26-005470, Size: 164 KB). The filing covers Item 2.02 (Results of Operations and Financial Condition) and Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers). No specific details on officers, reasons, financial metrics, or changes are provided.
07-01-2026
MOBIX LABS, INC filed a Form 8-K on January 07, 2026 (AccNo: 0001493152-26-000731, Size: 704 KB), reporting under Item 1.01 entry into a Material Definitive Agreement and under Item 9.01 Financial Statements and Exhibits. No specific details on the agreement, transaction value, parties involved, or financial impacts are disclosed in the provided information. Sector is not specified.
07-01-2026
VisionWave Holdings, Inc. filed an 8-K on January 7, 2026 (AccNo: 0001731122-26-000018, Size: 438 KB), disclosing entry into a material definitive agreement (Item 1.01) and completion of an acquisition or disposition of assets (Item 2.01). The filing also reports unregistered sales of equity securities (Item 3.02) and provides financial statements and exhibits (Item 9.01). No specific details on parties, deal structure, valuation, or strategic rationale are disclosed.
07-01-2026
SAB Biotherapeutics, Inc. disclosed an officer change via Form 8-K filed on January 07, 2026 (AccNo: 0001193125-26-005487, Size: 268 KB), under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). The filing also includes Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). No specific details on the officer, position, appointment/resignation, reasons, or quantitative data are provided in the summary.
07-01-2026
Tredegar Corp filed a Form 8-K on January 7, 2026 (AccNo: 0001193125-26-005481, Size: 133 KB), disclosing an officer change under Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. No specific details on the key position affected, appointment or resignation status, reasons, individuals involved, or quantitative data are provided in the summary. Sector is not specified.
07-01-2026
The company filed a Form 8-K on January 07, 2026 (AccNo: 0001999371-26-000372, Size: 615 KB) as a Material Event, reporting under Item 1.01 entry into a material definitive agreement and under Item 2.03 creation of a direct financial obligation or an obligation under an off-balance sheet arrangement of the registrant. Item 9.01 discloses financial statements and exhibits. No specific details on the agreement, obligation, transaction value, or parties are provided.
07-01-2026
Joby Aviation, Inc. filed a Form 8-K on January 7, 2026 (AccNo: 0001819848-26-000040, Size: 982 KB), reporting under Item 1.01 Entry into a Material Definitive Agreement, Item 7.01 Regulation FD Disclosure, and Item 9.01 Financial Statements and Exhibits. No details on the agreement, disclosures, transaction value, or financial impacts are explicitly stated. Sector not specified.
07-01-2026
Cidara Therapeutics, Inc. filed an 8-K on 2026-01-07 (AccNo: 0001193125-26-005517) disclosing termination of a material definitive agreement (Item 1.02), completion of acquisition or disposition of assets (Item 2.01), notice of delisting or failure to satisfy listing standards (Item 3.01), material modifications to rights of security holders (Item 3.03), changes in control of registrant (Item 5.01), departure/election of directors/officers and compensatory arrangements (Item 5.02), amendments to articles of incorporation or bylaws (Item 5.03), and financial statements/exhibits (Item 9.01). No specific parties, deal values, or financial metrics are disclosed. This indicates completion of a merger/acquisition event with resulting delisting and governance changes.
07-01-2026
T-REX Acquisition Corp. filed an 8-K on January 7, 2026 (AccNo: 0001477932-26-000053, Size: 127 KB) under Item 5.02, disclosing matters related to departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No details on any merger, acquisition, or transaction structure are mentioned in the filing summary. Sector is not specified.
07-01-2026
Alaska Air Group, Inc. filed a Form 8-K on January 7, 2026 (AccNo: 0000766421-26-000004, Size: 167 KB), reporting under Item 1.01 entry into a material definitive agreement and under Item 9.01 financial statements and exhibits. No details on the agreement, counterparties, transaction value, financial impacts, or other specifics are disclosed in the provided summary. This is a multi-item filing focused on a material event.
07-01-2026
Marqeta, Inc. disclosed an officer change via Form 8-K filed on January 7, 2026 (AccNo: 0001522540-26-000004, Size: 184 KB), under Item 5.02 covering departures, elections, appointments, or compensatory arrangements of certain officers, and Item 9.01 for financial statements and exhibits. No specific details on the affected officer, position, reason, or terms are provided. Sector is not specified.
07-01-2026
Ameriserv Financial Inc./PA/ filed a Form 8-K on January 7, 2026 (AccNo: 0001104659-26-001622, Size: 293 KB), reporting entry into a material definitive agreement under Item 1.01 and unregistered sales of equity securities under Item 3.02, with financial statements and exhibits attached under Item 9.01. This is a multi-item mandatory disclosure as a material event. No specific details on the agreement, sales, transaction values, or financial impacts are disclosed in the provided summary.
07-01-2026
Starwood Real Estate Income Trust, Inc. filed a Form 8-K on 2026-01-07 (AccNo: 0001193125-26-005534, Size: 153 KB) disclosing an officer change under Item 5.02 related to Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. No specific details on the officer, position, reason for change, or any quantitative data are provided in the available information. Sector is not specified.
07-01-2026
Enliven Therapeutics, Inc. filed a Form 8-K on January 7, 2026 (AccNo: 0001193125-26-005535, Size: 166 KB), disclosing an officer change under Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. Item 9.01 indicates Financial Statements and Exhibits were included. No specific details on the affected officer, position, appointment/resignation status, or reasons are provided in the summary.
07-01-2026
ASP Isotopes Inc. filed an 8-K on 2026-01-07 (AccNo: 0001477932-26-000055, Size: 185 KB) disclosing completion of an acquisition or disposition of assets (Item 2.01), unregistered sales of equity securities (Item 3.02), other events (Item 8.01), and financial statements and exhibits (Item 9.01). No specific details on parties, deal structure, valuation, or quantitative metrics are provided. Sector not specified.
07-01-2026
FuboTV Inc. filed a Form 8-K on January 7, 2026 (AccNo: 0001493152-26-000807, Size: 449 KB), reporting entry into a material definitive agreement under Item 1.01, creation of a direct financial obligation or off-balance sheet arrangement under Item 2.03, Regulation FD disclosure under Item 7.01, and financial statements and exhibits under Item 9.01. This is a multi-item filing classified as a Material Event from US SEC source. No specific transaction details, dollar values, parties, or financial metrics are disclosed in the provided filing summary.
07-01-2026
BiomX Inc. filed an 8-K on 2026-01-07 (AccNo: 0001213900-26-002160, Size: 253 KB) reporting the termination of a material definitive agreement under Item 1.02 and financial statements and exhibits under Item 9.01. No details on the agreement, counterparties, dollar values, or financial impacts are disclosed in the provided summary. Sector not specified.
07-01-2026
Atmus Filtration Technologies Inc. filed a Form 8-K on January 7, 2026 (AccNo: 0001921963-26-000004, Size: 68 MB), disclosing under Item 1.01 entry into a material definitive agreement, Item 2.03 creation of a direct financial obligation or off-balance sheet arrangement, Item 7.01 Regulation FD disclosure, and Item 9.01 financial statements and exhibits. No specific details on transaction value, counterparties, financial impacts, or strategic rationale are provided in the available information. This is a multi-item mandatory filing for material events.
07-01-2026
TRANSUITE.ORG INC. filed an 8-K on 2026-01-07 (AccNo: 0001640334-26-000042, Size: 231 KB) disclosing Item 1.01 Entry into a Material Definitive Agreement, Item 2.01 Completion of Acquisition or Disposition of Assets, Item 3.02 Unregistered Sales of Equity Securities, and Item 9.01 Financial Statements and Exhibits. No specific details on deal structure, parties, valuation, consideration, or strategic rationale are provided in the summary. All quantitative metrics such as transaction value, share counts, or financial impacts are NOT_DISCLOSED.
07-01-2026
SPECTRAL CAPITAL Corp filed a Form 8-K on January 07, 2026 (AccNo: 0001096906-26-000033, Size: 179 KB) disclosing Entry into a Material Definitive Agreement under Item 1.01 and Financial Statements and Exhibits under Item 9.01. Sector not specified. No details on the agreement, transaction value, parties, or financial impacts provided.
07-01-2026
Columbus Acquisition Corp, a Cayman Islands entity, filed an 8-K on January 7, 2026 (AccNo: 0001213900-26-002088, size: 341 KB) announcing a merger/acquisition event under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on deal structure, parties involved, valuation, consideration, or strategic rationale are disclosed in the provided filing summary. Sector is not specified.
07-01-2026
Unnamed company filed an 8-K on 2026-01-07 (AccNo: 0001193125-26-006078, Size: 165 KB) disclosing Item 3.02 Unregistered Sales of Equity Securities and Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. Event classified as Officer Change dated January 07, 2026 from US SEC source. No specific details on officer name, position, appointment/resignation, reasons, compensation, or transaction terms provided.
07-01-2026
American Clean Resources Group, Inc. disclosed an officer change event via Form 8-K filed on January 07, 2026 (AccNo: 0001213900-26-002127, Size: 194 KB), covering Item 3.02 Unregistered Sales of Equity Securities and Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. No specific details on positions affected, individuals involved, reasons for change, or quantitative data provided. Sector not specified.
07-01-2026
PSQ Holdings, Inc. filed a Form 8-K on 2026-01-07 (AccNo: 0001104659-26-001573, size 396 KB) disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers), alongside results of operations and financial condition (Item 2.02), Regulation FD disclosure (Item 7.01), and financial statements/exhibits (Item 9.01). Specific details on the officer position, appointment/resignation status, reasons, named individuals, quantitative financial metrics, or governance impacts are NOT_DISCLOSED. Sector not specified.
07-01-2026
CF Industries Holdings, Inc. disclosed an Officer Change event via Form 8-K filed on January 7, 2026 (AccNo: 0001104659-26-001551, Size: 190 KB). The filing pertains to Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. No specific details on the affected officer, position, reason for change, or quantitative data are provided in the available summary.
07-01-2026
National Bank Holdings Corp filed an 8-K on 2026-01-07 (AccNo: 0001104659-26-001549, Size: 264 KB) announcing completion of an acquisition or disposition of assets under Item 2.01. The filing also covers departure or election of directors/officers and compensatory arrangements under Item 5.02, other events under Item 8.01, and financial statements/exhibits under Item 9.01. No specific details on parties, valuation, structure, or financial metrics are disclosed.
07-01-2026
Diversified Energy Co filed an 8-K on January 7, 2026 (AccNo: 0001140361-26-000434, Size: 284 KB), disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers) and Item 9.01 (Financial Statements and Exhibits). No specific details on the affected officer, position, reason for change, or any quantitative data provided in the available information. Sector not specified.
07-01-2026
Centessa Pharmaceuticals plc filed a Form 8-K on January 7, 2026 (AccNo: 0001193125-26-004896, Size: 361 KB), reporting an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers) and Item 9.01 (Financial Statements and Exhibits). No specific details on the affected officer, position, reason for change, or any quantitative data such as transaction values, share counts, or percentages are disclosed in the provided information. Sector is not specified.
07-01-2026
Archrock, Inc. filed an 8-K on January 07, 2026 (AccNo: 0001104659-26-001481, Size: 618 KB) reporting Item 1.01 Entry into a Material Definitive Agreement, Item 7.01 Regulation FD Disclosure, and Item 9.01 Financial Statements and Exhibits. This is a multi-item mandatory filing from US SEC source in an unspecified sector. No core event details, transaction values, financial metrics, or other specifics are disclosed in the provided information.
07-01-2026
Sow Good Inc. filed a Form 8-K on 2026-01-07 (AccNo: 0001193125-26-004866, Size: 198 KB) disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits). No specific details on the affected officer, position (e.g., CEO, CFO), appointment or resignation, reasons, or any quantitative data are provided. Event dated January 07, 2026; sector not specified.
07-01-2026
Aon plc filed a Form 8-K on January 7, 2026 (AccNo: 0001193125-26-005392, Size: 406 KB) disclosing an officer change under Item 5.02, covering departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. Item 9.01 references financial statements and exhibits. No specific details on the affected officer, position, reason for change, or quantitative data are provided.
07-01-2026
COMPASS Pathways plc filed a Form 8-K on January 07, 2026 (AccNo: 0001816590-26-000004), reporting under Item 1.01 (Entry into a Material Definitive Agreement) and Item 2.03 (Creation of a Direct Financial Obligation or Off-Balance Sheet Arrangement), with exhibits under Item 9.01. No specific details on the agreement, transaction value, or financial terms are disclosed in the provided filing summary. This is a multi-item mandatory filing likely within the required 4-business-day window.
07-01-2026
High Roller Technologies, Inc. filed an 8-K on January 07, 2026 (AccNo: 0001753926-26-000064, Size: 169 KB) under Item 2.01 announcing the completion of an acquisition or disposition of assets. No details on parties involved, deal structure, valuation, strategic rationale, or financial impacts are disclosed in the provided filing summary. Sector is not specified.
07-01-2026
SharkNinja, Inc. filed a Form 8-K on 2026-01-07 (AccNo: 0001957132-26-000003, Size: 155 KB) disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers) and Item 9.01 (Financial Statements and Exhibits). No specific details on the affected officer, position, appointment/resignation status, reasons, or compensation are disclosed in the provided summary. Sector is not specified.
07-01-2026
Apogee Enterprises, Inc. filed a Form 8-K on January 7, 2026 (AccNo: 0000006845-26-000006, Size: 522 KB), disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). No specific details on the affected officer, position (e.g., CEO, CFO), nature of change (appointment or resignation), reasons, or timing are explicitly stated. No quantitative financial metrics, transaction values, share counts, or percentages are mentioned.
07-01-2026
D-Wave Quantum Inc. filed a Form 8-K on 2026-01-07 (AccNo: 0001907982-26-000010, Size: 41 MB) reporting Item 1.01 (Entry into a Material Definitive Agreement), Item 3.02 (Unregistered Sales of Equity Securities), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing with no specific details on transaction value, share counts, parties involved, financial impacts, or other quantitative data disclosed in the provided summary. Sector is not specified.
07-01-2026
NRG Energy, Inc. filed a Form 8-K on January 7, 2026 (AccNo: 0001104659-26-001602, Size: 276 KB) disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements). The filing also includes Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. No specific details on the officer, position, appointment/resignation status, reasons, or quantitative data are disclosed in the provided filing summary.
07-01-2026
The company filed an 8-K on 2026-01-07 (AccNo: 0001185185-26-000046, Size: 197 KB) under Item 4.02 announcing non-reliance on previously issued financial statements or a related audit report or completed interim review. This event is typed as Merger/Acquisition with no sector specified. No parties, deal structure, valuation, or financial metrics are disclosed.
07-01-2026
Extreme Networks Inc. (EXTREME NETWORKS INC) filed a Form 8-K on January 7, 2026 (AccNo: 0001193125-26-005441, Size: 160 KB), disclosing an officer change under Item 5.02 related to Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. No specific details on the affected position (e.g., CEO, CFO), individual names, appointment/resignation status, reasons, or quantitative data such as compensation amounts, share counts, or transaction values are provided in the filing summary. Sector is not specified.
07-01-2026
CoStar Group, Inc. filed a Form 8-K on January 7, 2026 (AccNo: 0001057352-26-000004, Size: 7 MB), disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements), Regulation FD Disclosure under Item 7.01, and Financial Statements and Exhibits under Item 9.01. No specific details on the affected officer, position, reason for change, names, or quantitative data are provided in the filing summary. Sector is not specified.
07-01-2026
Anterix Inc. filed a Form 8-K on January 7, 2026 (AccNo: 0001304492-26-000002, Size: 142 KB) under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals involved, reasons for change, or terms are disclosed in the provided summary. Sector is not specified.
07-01-2026
FUELCELL ENERGY INC filed a Form 8-K on January 07, 2026 (AccNo: 0001104659-26-001597, Size: 282 KB) disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits). No specific details on the affected officer, position, reason for change, or quantitative data are provided in the filing summary. Sector not specified.
07-01-2026
Inotiv, Inc. filed a Form 8-K on January 07, 2026 (AccNo: 0001628280-26-001160) reporting under Item 3.01 a Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. No specific details on delisting reasons, financial impacts, transaction values, or other quantitative data are disclosed. Sector is not specified.
07-01-2026
Terra Innovatum Global N.V. filed a Form 8-K on January 07, 2026 (AccNo: 0001213900-26-002159, Size: 215 KB) disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers) and Item 9.01 (Financial Statements and Exhibits). No details on the specific officer, position affected, appointment/resignation status, reasons, or any quantitative data are provided in the summary. Sector is not specified.
07-01-2026
DT Cloud Star Acquisition Corp filed an 8-K on January 7, 2026 (AccNo: 0001493152-26-000803, Size: 265 KB) under Item 8.01 Other Events announcing a Merger/Acquisition. No specific deal structure, parties involved, valuation, consideration, synergies, regulatory details, or financial metrics are disclosed. Sector not specified.
07-01-2026
GridAI Technologies Corp. filed an 8-K on 2026-01-07 (AccNo: 0001104659-26-001755, Size: 313 KB) under Item 2.01 announcing the Completion of Acquisition or Disposition of Assets. Item 9.01 discloses Financial Statements and Exhibits. No details on parties involved, deal structure, valuation, or strategic rationale are provided.
07-01-2026
COGENT COMMUNICATIONS HOLDINGS, INC. filed a Form 8-K on January 7, 2026 (AccNo: 0001104659-26-001748, Size: 265 KB) disclosing an officer change under Item 5.02. Item 5.02 covers departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. Item 9.01 includes financial statements and exhibits; no specific details on individuals, positions, reasons, or compensation provided.
07-01-2026
BCB Bancorp Inc filed a Form 8-K on January 7, 2026 (AccNo: 0001193125-26-006261, Size: 132 KB), disclosing an officer change under Item 5.02 related to Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. No specific details on the affected officer, position (e.g., CEO, CFO), nature of change (appointment or resignation), reasons, or any quantitative data are provided in the summary. Sector is not specified.
07-01-2026
Healthcare Realty Trust Inc filed a Form 8-K on 2026-01-07 (AccNo: 0001360604-26-000009, Size: 338 KB) disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). No specific details on the officer's name, title, reason for change, or other quantitative data are provided. Event dated January 07, 2026; sector not specified.
07-01-2026
Turn Therapeutics Inc. filed a Form 8-K on 2026-01-07 (AccNo: 0001213900-26-002173, Size: 38 MB) disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). Event occurred on January 07, 2026. No specific details on the officer involved, position, appointment/resignation status, reasons, or quantitative data are disclosed in the provided summary.
07-01-2026
Photronics Inc filed a Form 8-K on January 7, 2026 (AccNo: 0001140361-26-000510, size: 1 MB), disclosing an officer change under Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. Item 9.01 references Financial Statements and Exhibits. No specific details on the affected officer, position, appointment or resignation status, reasons, or quantitative data are provided.
07-01-2026
BION ENVIRONMENTAL TECHNOLOGIES INC filed a Form 8-K on January 07, 2026 (AccNo: 0001079973-26-000047, Size: 182 KB), reporting under Item 1.01 Entry into a Material Definitive Agreement and Item 9.01 Financial Statements and Exhibits. No details on the agreement, transaction value, counterparties, or financial impacts are disclosed in the provided information. Sector is not specified.
07-01-2026
Medalist Diversified REIT, Inc. disclosed an officer change via Form 8-K filed on January 7, 2026 (AccNo: 0001104659-26-001772, size 153 KB). The filing pertains to Item 5.02, covering departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements. No specific details on positions affected, individuals involved, reasons, or financial terms are provided.
07-01-2026
Venus Concept Inc. filed an 8-K on January 7, 2026 (AccNo: 0001140361-26-000509, Size: 288 KB), reporting under Item 1.01 entry into a Material Definitive Agreement and under Item 9.01 Financial Statements and Exhibits. No details on the agreement, transaction value, parties, financial impacts, or other specifics are disclosed in the provided summary. Sector not specified.
07-01-2026
OMEGA HEALTHCARE INVESTORS INC filed a Form 8-K on 2026-01-07 (AccNo: 0001104659-26-001774, Size: 193 KB) reporting an officer change under Item 5.02. Item 5.02 addresses Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. No details on specific officers, positions affected, appointment or resignation status, reasons, or quantitative financial data are disclosed.
07-01-2026
NEXGEL, INC. filed a Form 8-K on January 7, 2026 (AccNo: 0001493152-26-000813, Size: 257 KB) disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers). Item 9.01 includes Financial Statements and Exhibits. No specific details on the officer, position, appointment/resignation, reasons, or quantitative data are provided.
07-01-2026
Evergy, Inc. filed a Form 8-K on January 07, 2026 (AccNo: 0001193125-26-006331, Size: 670 KB), reporting under Item 1.01 (Entry into a Material Definitive Agreement), Item 2.03 (Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item mandatory filing for material corporate events involving agreements and financial obligations. No specific transaction details, dollar values, parties, or quantitative impacts are disclosed in the provided filing summary.
07-01-2026
Aeries Technology, Inc. filed a Form 8-K on January 7, 2026 (AccNo: 0001829126-26-000086, size 257 KB), reporting under Item 1.01 entry into a Material Definitive Agreement. Item 9.01 discloses Financial Statements and Exhibits. No details on the agreement, transaction value, or other specifics are provided.
07-01-2026
Ecovyst Inc. filed an 8-K on January 7, 2026 (AccNo: 0001708035-26-000010, Size: 369 KB) announcing completion of an acquisition or disposition of assets (Item 2.01), triggering events that accelerate or increase direct financial obligations or off-balance sheet arrangements (Item 2.04), and departure/election of directors or officers with compensatory arrangements (Item 5.02), including financial statements and exhibits (Item 9.01). No specific details on transaction parties, structure, value, or financial metrics are disclosed. Sector not specified.
07-01-2026
Black Stone Minerals, L.P. filed a Form 8-K on January 7, 2026 (AccNo: 0001621434-26-000005, Size: 166 KB), disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers). Item 9.01 indicates financial statements and exhibits were included. No specific details on the officer's position, name, appointment/departure status, reasons, or quantitative data are disclosed in the provided filing summary.
07-01-2026
HEARTLAND EXPRESS INC filed a Form 8-K on January 7, 2026 (AccNo: 0000799233-26-000002, Size: 139 KB) disclosing an officer change under Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. No specific details on the officer involved, nature of change (appointment or resignation), reasons, or quantitative data are provided in the filing summary. Sector is not specified.
07-01-2026
APPYEA, INC filed an 8-K on January 07, 2026 (AccNo: 0001493152-26-000819, Size: 5 MB) announcing entry into a material definitive agreement (Item 1.01) and completion of an acquisition or disposition of assets (Item 2.01). The filing also covers unregistered sales of equity securities (Item 3.02), departure/election/appointment of directors/officers and compensatory arrangements (Item 5.02), and amendments to articles of incorporation or bylaws or change in fiscal year (Item 5.03), with financial statements and exhibits (Item 9.01). No specific parties, deal structure, valuation, or financial terms are disclosed.
07-01-2026
agilon health, inc. filed a Form 8-K on January 07, 2026 (AccNo: 0001628280-26-001168, Size: 147 KB) disclosing an Item 5.02 event related to Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. No specific details on affected officers, appointment/resignation type, reasons, or quantitative data are explicitly stated in the provided filing summary. Sector is not specified.
07-01-2026
The company filed a Form 8-K on January 7, 2026 (AccNo: 0000899689-26-000003, size 244 KB) reporting Item 1.01 (Entry into a Material Definitive Agreement) and Item 2.03 (Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement). This is classified as a Material Event. No specific details on the agreement, transaction value, parties, or financial terms are disclosed in the provided filing summary.
07-01-2026
M-tron Industries, Inc. filed a Form 8-K on January 7, 2026 (AccNo: 0001437749-26-000790, Size: 691 KB), reporting entry into a material definitive agreement under Item 1.01 and creation of a direct financial obligation or off-balance sheet arrangement under Item 2.03, with financial statements and exhibits under Item 9.01. This is a multi-item mandatory filing as a material event. No specific transaction details, dollar values, parties, or financial metrics are disclosed.
07-01-2026
Constellation Energy Corp filed an 8-K on January 07, 2026 (AccNo: 0001104659-26-001780, size 13 MB) reporting a Merger/Acquisition event, including Item 1.01 (Entry into a Material Definitive Agreement), Item 2.01 (Completion of Acquisition or Disposition of Assets), Item 2.03 (Creation of a Direct Financial Obligation), Item 3.02 (Unregistered Sales of Equity Securities), Item 5.02 (Changes in Directors/Officers), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). No specific details on parties, deal structure, valuation, or financial metrics are disclosed in the provided filing summary. Sector is not specified.
07-01-2026
Kaiser Aluminum Corp disclosed an officer change via Form 8-K filed on January 7, 2026 (AccNo: 0001193125-26-006395, Size: 268 KB), under Item 5.02 covering departures or elections of directors/officers and compensatory arrangements. Item 9.01 indicates financial statements and exhibits are included. No specific details on the officer's identity, position, appointment/resignation status, or reasons are provided.
07-01-2026
Interactive Strength, Inc. filed a Form 8-K on January 07, 2026 (AccNo: 0001193125-26-006397, Size: 289 KB), reporting multiple material events under Items 1.01 (Entry into a Material Definitive Agreement), 2.03 (Creation of a Direct Financial Obligation or Off-Balance Sheet Arrangement), 3.02 (Unregistered Sales of Equity Securities), 3.03 (Material Modifications to Rights of Security Holders), 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements), and 9.01 (Financial Statements and Exhibits). No specific details on transaction values, parties involved, dollar amounts, share counts, or other quantitative metrics are disclosed in the provided filing summary. This is a multi-item mandatory filing with no timing details on business hours compliance available.
07-01-2026
NON INVASIVE MONITORING SYSTEMS INC /FL/ filed a Form 8-K on January 7, 2026 (AccNo: 0001493152-26-000822, size: 446 KB), reporting under Item 1.01 entry into a material definitive agreement and under Item 2.03 creation of a direct financial obligation or an obligation under an off-balance sheet arrangement, with Item 9.01 financial statements and exhibits. No specific details on the agreement, obligation, transaction value, parties, or financial metrics are disclosed in the provided filing summary. Sector is not specified.
07-01-2026
Jasper Therapeutics, Inc. filed a Form 8-K on January 07, 2026 (AccNo: 0001213900-26-002185, Size: 289 KB), disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), other events under Item 8.01, and financial statements/exhibits under Item 9.01. No specific details on the affected officer, position, appointment/resignation status, reasons, or quantitative data are provided in the filing summary. Sector is not specified.
07-01-2026
Ventas, Inc. filed an 8-K on January 7, 2026 (AccNo: 0001104659-26-001785, Size: 1 MB), reporting under Item 1.01 (Entry into a Material Definitive Agreement), Item 2.03 (Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item mandatory disclosure of a material event. No specific transaction details, dollar values, or other quantitative data are disclosed in the provided filing summary.
07-01-2026
Biofrontera Inc. filed a Form 8-K on 2026-01-07 (AccNo: 0001493152-26-000823, Size: 267 KB) reporting under Item 3.01 a Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. This is a single-item mandatory disclosure likely filed promptly upon receipt of notice. No details on delisting reasons, financial impacts, transaction values, or sector are disclosed.
07-01-2026
MSP Recovery, Inc. filed a Form 8-K on January 7, 2026 (AccNo: 0001193125-26-006375, Size: 270 KB), reporting under Item 1.01 entry into a material definitive agreement, under Item 2.03 creation of a direct financial obligation or obligation under an off-balance sheet arrangement, and under Item 9.01 financial statements and exhibits. This is a multi-item mandatory filing with no specific transaction details, dollar values, parties, or financial metrics disclosed in the provided information.
07-01-2026
Commerce.com, Inc. filed a Form 8-K on 2026-01-07 (AccNo: 0001193125-26-006391, Size: 170 KB) disclosing results of operations and financial condition (Item 2.02), costs associated with exit or disposal activities (Item 2.05), departure of directors or certain officers, election/appointment of directors/officers, or compensatory arrangements (Item 5.02), and financial statements/exhibits (Item 9.01). Specific details on officer changes, financial metrics, or reasons are NOT_DISCLOSED. Event type is Officer Change from US SEC source.
07-01-2026
Greystone Housing Impact Investors LP filed a Form 8-K on January 07, 2026 (AccNo: 0001193125-26-006382, Size: 2 MB), reporting under Item 1.01 entry into a material definitive agreement and under Item 2.03 creation of a direct financial obligation or off-balance sheet arrangement. Item 9.01 includes financial statements and exhibits. No specific transaction details, dollar values, or other quantitative data are disclosed in the provided filing summary.
07-01-2026
Charles & Colvard Ltd disclosed an officer change via Form 8-K filed on January 7, 2026 (AccNo: 0001104659-26-001804, Size: 181 KB) under Item 5.02, covering Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. No specific details on the affected position, individual names, appointment or resignation status, reasons, or quantitative data are provided in the available information. Sector is not specified.
07-01-2026
Oncotelic Therapeutics, Inc. filed a Form 8-K on January 7, 2026 (AccNo: 0001493152-26-000821, Size: 225 KB), reporting under Item 1.01 entry into a material definitive agreement, Item 2.03 creation of a direct financial obligation or off-balance sheet arrangement, Item 3.02 unregistered sales of equity securities, and Item 9.01 financial statements and exhibits. No specific details on the agreement, transaction value, parties, share counts, or financial impacts are disclosed in the provided filing summary. This is a multi-item mandatory filing for material events.
07-01-2026
Warner Bros. Discovery, Inc. filed an 8-K on January 07, 2026, reporting under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers) and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing with no specific details on individuals, transactions, or numerical values disclosed in the provided summary. All quantitative data and named entities beyond the filer are NOT_DISCLOSED.
07-01-2026
Event typed as Administration (voluntary administration under Corporations Act 2001 s436A) for Company (Ansell referenced) on January 07, 2026, but announcement details only CEO retirement and new CEO appointment with no insolvency process specifics, creditor details, or asset/debt disclosures. No information provided on secured/unsecured creditor implications, recovery prospects, or stakeholder impacts like employee entitlements or director liabilities, rendering creditor return expectations (cents in the dollar) and timeline NOT_DISCLOSED. ASIC oversight for director duties and potential investigations remains unassessable absent financial position data.
07-01-2026
Innovative Food Holdings Inc filed a Form 8-K on January 7, 2026 (AccNo: 0001185185-26-000059, Size: 8 MB), reporting under Item 1.01 (Entry into a Material Definitive Agreement), Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). No specific details on the agreement, personnel changes, events, or exhibits are provided in the summary. Sector is not specified.
07-01-2026
ALTA Equipment Group Inc. disclosed an officer change via Form 8-K filed on January 7, 2026 (AccNo: 0001193125-26-006446, Size: 479 KB), under Item 5.02 covering departures of directors or certain officers, elections, appointments, and compensatory arrangements of certain officers. Item 9.01 notes financial statements and exhibits. No specific details on the officer involved, position, appointment/resignation status, reasons, or quantitative data are provided.
07-01-2026
TriUnity Business Services Ltd filed an 8-K on 2026-01-07 (AccNo: 0001477932-26-000074, Size: 6 MB) disclosing a merger/acquisition event under Items 1.01 (Entry into Material Definitive Agreement), 2.01 (Completion of Acquisition/Disposition of Assets), 3.02 (Unregistered Sales of Equity Securities), 5.02 (Changes in Directors/Officers), 5.03 (Amendments to Articles/Bylaws), and 9.01 (Financial Statements/Exhibits). Specific details on deal structure, parties involved, valuation, consideration type, synergies, regulatory pathway, shareholder impacts, or quantitative metrics such as transaction value, share counts, or percentages are NOT_DISCLOSED. Analysis limited to filing items triggered, indicating a completed material M&A with governance and equity changes.
07-01-2026
Zevia PBC filed a Form 8-K on January 7, 2026 (AccNo: 0001437749-26-000800, Size: 183 KB), disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), Regulation FD Disclosure under Item 7.01, and Financial Statements and Exhibits under Item 9.01. No specific details on the affected officer, position, appointment/resignation status, reasons, or any quantitative data are provided in the filing summary. Sector not specified.
07-01-2026
Resideo Technologies, Inc. filed a Form 8-K on January 7, 2026 (AccNo: 0001193125-26-006506, Size: 139 KB), disclosing an officer change under Item 5.02, which pertains to departures of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on the affected officer, position, nature of change (appointment or resignation), reasons, or any quantitative data are provided in the summary. Sector is not specified.
07-01-2026
Topgolf Callaway Brands Corp. filed an 8-K on January 7, 2026 (AccNo: 0000837465-26-000003, size 1 MB), disclosing entry into a material definitive agreement (Item 1.01) and completion of an acquisition or disposition of assets (Item 2.01), along with Regulation FD disclosure (Item 7.01) and financial statements/exhibits (Item 9.01). No specific details on parties involved, deal structure, valuation, or financial metrics were mentioned. Sector not specified.
07-01-2026
Toll Brothers, Inc. filed a Form 8-K on 2026-01-07 (AccNo: 0000794170-26-000006, Size: 761 KB) disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers), along with Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits). No specific details on the officer position, appointment/resignation status, reasons, or quantitative data are provided. Sector is not specified.
07-01-2026
Company filed an 8-K on 2026-01-07 (AccNo: 0001193125-26-006514, Size: 1 MB) as a Material Event reporting Item 1.01 (Entry into a Material Definitive Agreement), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item mandatory filing with event date January 07, 2026, from source us_sec; sector not specified. No details on the core event, transaction value, financial impacts, or named entities are disclosed.
07-01-2026
Windtree Therapeutics Inc./DE/ filed a Form 8-K on January 7, 2026 (AccNo: 0001437749-26-000805, Size: 145 KB), disclosing an officer change under Item 5.02 related to departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on the affected position, individual names, appointment/resignation status, reasons, or any numerical data are provided in the filing summary. Sector is not specified.
07-01-2026
Fat Brands, Inc. disclosed an officer change via Form 8-K filed on 2026-01-07 (AccNo: 0001493152-26-000827, Size: 321 KB) under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers) and Item 9.01 (Financial Statements and Exhibits). No specific details on the affected officer, position, reason for change, or compensatory arrangements are provided in the available information. Sector is not specified.
07-01-2026
SurgePays, Inc. filed a Form 8-K on January 7, 2026 (AccNo: 0001493152-26-000830, Size: 291 KB) under Item 5.02 disclosing a change involving departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements. Item 9.01 indicates financial statements and exhibits are included. No specific details on positions affected, individuals involved, reasons for change, or quantitative terms such as compensation amounts are disclosed.
07-01-2026
VisionWave Holdings, Inc. disclosed an officer change via Form 8-K filed on January 7, 2026 (AccNo: 0001731122-26-000023, size 313 KB). The filing covers Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers) and Item 9.01 (Financial Statements and Exhibits). No specific details on the officer position, appointment/resignation, reasons, or compensation are provided.
07-01-2026
Super League Enterprise, Inc. filed a Form 8-K on January 07, 2026 (AccNo: 0001437749-26-000808, Size: 556 KB), reporting under Item 1.01 (Entry into a Material Definitive Agreement), Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing with no specific details on transactions, values, names, or financial impacts disclosed in the provided summary. Sector not specified.
07-01-2026
Ventyx Biosciences, Inc. filed a Form 8-K on January 7, 2026 (AccNo: 0001193125-26-006520, Size: 936 KB), reporting under Item 1.01 Entry into a Material Definitive Agreement, Item 7.01 Regulation FD Disclosure, and Item 9.01 Financial Statements and Exhibits. This is a multi-item mandatory filing for material events, but specific details of the agreement, disclosures, or exhibits are NOT_DISCLOSED in the provided summary. No transaction values, financial impacts, or named counterparties are mentioned.
07-01-2026
The company filed a Form 8-K on January 7, 2026 (AccNo: 0001552781-26-000004, Size: 188 KB) reporting under Item 1.01 entry into a Material Definitive Agreement. Event date is January 7, 2026, classified as a Material Event from us_sec source. No details on the agreement parties, terms, value, or strategic context are disclosed in the provided filing summary; sector not specified.
07-01-2026
Oncology Institute, Inc. disclosed an officer change via Form 8-K filed on January 7, 2026 (AccNo: 0001079973-26-000051, Size: 251 KB), triggering Items 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), 7.01 (Regulation FD Disclosure), and 9.01 (Financial Statements and Exhibits). No specific details on the affected officer, position, reason for change, or any quantitative data provided in the filing summary. Sector not specified.
07-01-2026
Amerant Bancorp Inc. filed a Form 8-K on 2026-01-07 (AccNo: 0001734342-26-000004, Size: 6 MB), reporting under Item 1.01 entry into a Material Definitive Agreement and under Item 9.01 Financial Statements and Exhibits. No details on the agreement's nature, parties, value, or financial impacts are disclosed in the provided summary.
07-01-2026
Propanc Biopharma, Inc. filed a Form 8-K on 2026-01-07 (AccNo: 0001493152-26-000834, Size: 207 KB) under Item 3.01 announcing a notice of delisting or failure to satisfy a continued listing rule or standard, or transfer of listing from the US market. Sector is not specified. No additional details on reasons, financial impacts, or transaction values are disclosed.
07-01-2026
Sadot Group Inc. filed a Form 8-K on January 7, 2026 (AccNo: 0001731122-26-000022, Size: 258 KB), disclosing an officer change under Item 5.02, which covers departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. Item 9.01 indicates financial statements and exhibits are included. No specific details on individuals, reasons, compensation, or quantitative impacts are disclosed in the provided summary.
07-01-2026
EON Resources Inc. filed a Form 8-K on January 7, 2026 (AccNo: 0001213900-26-002201, Size: 240 KB) disclosing an officer change under Item 5.02. Item 5.02 covers Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. No specific details on positions affected, individuals involved, reasons, or quantitative data are disclosed in the provided information.
07-01-2026
Fresh Del Monte Produce Inc filed a Form 8-K on January 7, 2026 (AccNo: 0001047340-26-000003, Size: 138 KB) disclosing an officer change under Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. No specific details on the affected officer, position, appointment/resignation status, reasons, or any numerical data are provided in the available information. Sector is not specified.
07-01-2026
Cartica Acquisition Corp filed an 8-K on January 7, 2026 (AccNo: 0001104659-26-001822, Size: 320 KB), reporting the termination of a material definitive agreement under Item 1.02, other events under Item 8.01, and financial statements and exhibits under Item 9.01. No specific details on the agreement, parties, valuation, or rationale are disclosed in the provided filing summary. Sector is not specified.
07-01-2026
LGL GROUP INC filed a Form 8-K on January 7, 2026 (AccNo: 0001437749-26-000821, Size: 196 KB) disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), Regulation FD Disclosure under Item 7.01, and Financial Statements and Exhibits under Item 9.01. No specific details on the affected officer's position (e.g., CEO, CFO), appointment or resignation status, reasons, or any quantitative financial metrics are disclosed in the provided information. Sector is not specified.
07-01-2026
Senmiao Technology Ltd filed an 8-K on January 7, 2026 (AccNo: 0001213900-26-002216, Size: 1 MB), disclosing entry into a material definitive agreement (Item 1.01) and completion of an acquisition or disposition of assets (Item 2.01). The filing also covers departure/election of directors/officers and compensatory arrangements (Item 5.02) and includes financial statements/exhibits (Item 9.01). No specific details on parties, structure, valuation, or terms are disclosed.
07-01-2026
KB Home filed a Form 8-K on January 7, 2026 (AccNo: 0000795266-26-000009, Size: 182 KB), disclosing Item 5.02 related to departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements. No specific details on positions affected, appointment/resignation status, reasons, names, or quantitative data are provided in the available information. Sector is not specified.
07-01-2026
Montauk Renewables, Inc. filed a Form 8-K on 2026-01-07 (AccNo: 0001193125-26-006546, Size: 207 KB), reporting Item 1.01 Entry into a Material Definitive Agreement and Item 9.01 Financial Statements and Exhibits. This is a multi-item filing with no specific details on the agreement's counterparties, terms, value, or exhibits provided in the available information. All transaction specifics, financial impacts, and strategic context are NOT_DISCLOSED.
07-01-2026
Imunon, Inc. filed a Form 8-K on January 7, 2026 (AccNo: 0001493152-26-000841, Size: 212 KB) disclosing an event under Item 5.02 related to departure of directors or certain officers, election or appointment of directors or certain officers, or compensatory arrangements of certain officers. Item 9.01 references financial statements and exhibits. No specific details on positions affected, individuals involved, reasons, or quantitative data are provided.
07-01-2026
Texas Ventures Acquisition III Corp filed an 8-K on January 7, 2026 (AccNo: 0001104659-26-001830, Size: 386 KB) disclosing under Item 1.01 entry into a Material Definitive Agreement related to a Merger/Acquisition event. Item 9.01 includes Financial Statements and Exhibits. No specific parties, deal structure, valuation, or other details are disclosed in the provided filing summary.
07-01-2026
BLUM HOLDINGS, INC. filed a Form 8-K on January 7, 2026 (AccNo: 0001437749-26-000818, Size: 273 KB), reporting entry into a material definitive agreement (Item 1.01), unregistered sales of equity securities (Item 3.02), Regulation FD disclosure (Item 7.01), and financial statements and exhibits (Item 9.01). This is a multi-item mandatory filing with no specific transaction details, dollar values, share counts, or other quantitative data disclosed in the provided summary. Sector is not specified.
07-01-2026
Vivakor, Inc. filed a Form 8-K on 2026-01-07 (AccNo: 0001829126-26-000094, Size: 248 KB) reporting Items 1.01 (Entry into a Material Definitive Agreement), 3.02 (Unregistered Sales of Equity Securities), and 9.01 (Financial Statements and Exhibits). This is a multi-item filing with no specific details on the agreement, transaction value, share counts, or financial impacts disclosed in the provided information. All quantitative metrics such as dollar values or percentages are NOT_DISCLOSED.
07-01-2026
Arena Group Holdings, Inc. filed a Form 8-K on January 7, 2026 (AccNo: 0001493152-26-000851, Size: 383 KB), reporting under Item 1.01 (Entry into a Material Definitive Agreement), Item 2.03 (Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing with no specific details on the agreement, obligation, events, transaction values, counterparties, or financial metrics disclosed in the provided information. All quantitative and qualitative details beyond the items reported are NOT_DISCLOSED.
07-01-2026
RANGE IMPACT, INC. filed an 8-K on 2026-01-07 (AccNo: 0001493152-26-000850, Size: 4 MB) announcing entry into a material definitive agreement (Item 1.01), completion of acquisition or disposition of assets (Item 2.01), creation of a direct financial obligation or off-balance sheet arrangement (Item 2.03), other events (Item 8.01), and financial statements/exhibits (Item 9.01). No specific details on parties involved, deal structure, valuation, consideration, synergies, or regulatory aspects are disclosed in the provided filing summary. Sector is not specified.
07-01-2026
Onar Holding Corp filed an 8-K on January 7, 2026 (AccNo: 0001477932-26-000079) disclosing the completion of an acquisition or disposition of assets under Item 2.01, along with Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. No specific details on transaction parties, structure, value, or rationale are provided in the filing summary. Sector is not specified.
07-01-2026
Nixxy, Inc. filed a Form 8-K on January 7, 2026 (AccNo: 0001683168-26-000143, size 834 KB), reporting entry into a material definitive agreement under Item 1.01, Regulation FD disclosure under Item 7.01, and financial statements and exhibits under Item 9.01. No specific details on the agreement, transaction value, or financial impacts are disclosed in the provided filing summary. Sector is not specified.
07-01-2026
Jet.AI Inc. filed a Form 8-K on 2026-01-07 (AccNo: 0001493152-26-000847, Size: 556 KB) disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers). Item 9.01 indicates Financial Statements and Exhibits were included. No specific details on the officer position, appointment/resignation, reason, or compensation are disclosed.
07-01-2026
Tidal Commodities Trust I filed a Form 8-K on January 7, 2026 (AccNo: 0001999371-26-000395, Size: 194 KB), disclosing an event under Item 5.02 related to Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. No specific details on the affected officer position (e.g., CEO, CFO), whether it is an appointment or resignation, reasons for the change, or any named individuals are stated. Sector is not specified.
Get daily alerts with 5 investment signals, 4 risk alerts, 4 opportunities and full AI analysis of all 117 filings
🇺🇸 More from United States
View all →March 25, 2026
US Pre-Market SEC Filings Roundup — March 25, 2026
US Pre-Market SEC Filings Roundup
March 24, 2026
US Merger & Acquisition SEC Filings — March 24, 2026
US Merger & Acquisition SEC Filings
March 24, 2026
US Corporate Board Director Changes SEC Filings — March 24, 2026
US Corporate Board Director Changes SEC Filings
March 24, 2026
US Executive Officer Management Changes SEC — March 24, 2026
US Executive Officer Management Changes SEC